Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb randomized trial of gemcitabine + erlotinib vs gemcitabine in metastatic pancreatic cancer
2010-022599-30Phase 2Completed
- Sponsor
- Spanish Cooperative Group for Digestive Tumour Therapy
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in pancreatic cancer (PC) comparing Gemcitabine with Gemcitabine + erlotinib (2 arms). Primary endpoints: progression-free survival and overall survival. Started Oct 2010; status: completed.
02
Drugs
erlotinibgemcitabine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on 2010-022599-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022599-30.